Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950134-09-001965
Filing Date
2009-02-05
Accepted
2009-02-05 17:07:06
Documents
1
Group Members
ANDREW E. JONESBOULDER VENTURES IV L.P.BV PARTNERS IV, L.L.C.JOSH E. FIDLERKYLE LEFKOFFLAWRENCE M. MACKSPETER ROSHKO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d66172sc13g.htm SC 13G 161095
  Complete submission text file 0000950134-09-001965.txt   163410
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51477 | Film No.: 09573753
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1900 NINTH STREET, SUITE 200 BOULDER CO 80302
Business Address 1900 NINTH STREET, SUITE 200 BOULDER CO 80302 3034446950
BOULDER VENTURES IV ANNEX LP (Filed by) CIK: 0001165197 (see all company filings)

EIN.: 522289816 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G